{
  "id": "550c3d45a103b78016000008",
  "type": "factoid",
  "question": "What is the main component of the Lewy bodies?",
  "ideal_answer": "Parkinson's disease (PD) is characterized by the progressive degeneration of substantia nigra pars compacta (SNpc) dopaminergic neurones and the formation of Lewy bodies (LB) in a proportion of the remaining neurones. Alpha-synuclein has been identified as the main component of the Lewy bodies.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23300799",
    "http://www.ncbi.nlm.nih.gov/pubmed/23295909",
    "http://www.ncbi.nlm.nih.gov/pubmed/15541000",
    "http://www.ncbi.nlm.nih.gov/pubmed/20534649",
    "http://www.ncbi.nlm.nih.gov/pubmed/22923347",
    "http://www.ncbi.nlm.nih.gov/pubmed/11412709",
    "http://www.ncbi.nlm.nih.gov/pubmed/20846907",
    "http://www.ncbi.nlm.nih.gov/pubmed/16969096",
    "http://www.ncbi.nlm.nih.gov/pubmed/18991634",
    "http://www.ncbi.nlm.nih.gov/pubmed/23183883",
    "http://www.ncbi.nlm.nih.gov/pubmed/10327208",
    "http://www.ncbi.nlm.nih.gov/pubmed/21683963",
    "http://www.ncbi.nlm.nih.gov/pubmed/21937912",
    "http://www.ncbi.nlm.nih.gov/pubmed/23382946",
    "http://www.ncbi.nlm.nih.gov/pubmed/22843682",
    "http://www.ncbi.nlm.nih.gov/pubmed/15530662",
    "http://www.ncbi.nlm.nih.gov/pubmed/23562579",
    "http://www.ncbi.nlm.nih.gov/pubmed/23384565",
    "http://www.ncbi.nlm.nih.gov/pubmed/11085897",
    "http://www.ncbi.nlm.nih.gov/pubmed/16951579",
    "http://www.ncbi.nlm.nih.gov/pubmed/24597591"
  ],
  "snippets": [
    {
      "text": "\u03b1-syn is the main component of Lewy bodies in Parkinson's disease (PD) and Lewy body dementia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23562579",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Parkinson's disease (PD) is one of the most common neurodegenerative diseases. Majority of PD are sporadic, for which genetic causes remain largely unknown. Alpha-synuclein, the main component of Lewy bodies, plays a central role in the PD pathogenesis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23384565",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Parkinson's disease (PD) is characterized by the progressive degeneration of substantia nigra pars compacta (SNpc) dopaminergic neurones and the formation of Lewy bodies (LB) in a proportion of the remaining neurones. \u03b1-synuclein is the main component of LB, but the pathological mechanisms that lead to neurodegeneration associated with LB formation remain unclear",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23382946",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "\u03b1-Synuclein is the main component of Lewy bodies, the intraneuronal inclusion bodies characteristic of Parkinson's disease",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23300799",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Parkinson's disease (PD) is the second most common neurodegenerative disease. The majority of PD cases are sporadic, for which genetic causes and underlying molecular mechanisms remain largely unclear. Autophagy, a highly conserved cellular process that governs the breakdown of long-lived proteins and organelles, has been involved in the degradation of \u03b1-synuclein (\u03b1-Syn), the main component of Lewy bodies",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23295909",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The main component of Lewy bodies is alpha-synuclein",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18991634",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Alpha-synuclein, a main component of Lewy bodies in synucleinopathies and senile plaques in Alzheimer disease, is centrally involved in neurodegeneration",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16951579",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15541000",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15530662",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The pre-synaptic protein alpha-synuclein is the main component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20534649",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Specifically, identification of Lewy bodies in fetal mesencephalic neurons transplanted in patients with Parkinson's disease raised the hypothesis that \u03b1-synuclein, the main component of Lewy bodies, could be transmitted from the host brain to a graft of healthy neurons.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20846907",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "LBD has neuropathological characteristics whereby numerous Lewy bodies are present in the central and sympathetic nervous systems, and it is a type of alpha-synucleinopathy because the main component of Lewy body is alpha-synuclein.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24597591",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16969096",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The main component of Lewy bodies is alpha-synuclein.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18991634",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The main component of Lewy bodies is alpha-synuclein (AS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22923347",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15530662",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Alpha-synuclein, a main component of Lewy bodies in synucleinopathies and senile plaques in Alzheimer disease, is centrally involved in neurodegeneration.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16951579",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "\ufffd-Synuclein is the main component of Lewy bodies, the intraneuronal inclusion bodies characteristic of Parkinsons disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23300799",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In the 1990s, \ufffd-synuclein was identified as the main constituent of the Lewy pathology, and its aggregation was shown to be central to PD, dementia with Lewy bodies, and multiple system atrophy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23183883",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Identification of protein interfaces between \ufffd-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22843682",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Fibrillar \ufffd-synuclein (\ufffd-Syn) is the principal component of Lewy bodies, which are evident in individuals affected by Parkinson disease (PD).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22843682",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "\ufffd-Synuclein is a major component of Lewy bodies in Parkinson disease (PD) and dementia with Lewy bodies (DLB).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21937912",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The main component of Lewy bodies is alpha-synuclein.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18991634",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16969096",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Specifically, identification of Lewy bodies in fetal mesencephalic neurons transplanted in patients with Parkinson's disease raised the hypothesis that \u00ce\u00b1-synuclein, the main component of Lewy bodies, could be transmitted from the host brain to a graft of healthy neurons.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20846907",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15541000",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11412709",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16969096",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The main component of Lewy bodies is alpha-synuclein (AS)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22923347",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Specifically, identification of Lewy bodies in fetal mesencephalic neurons transplanted in patients with Parkinson's disease raised the hypothesis that \u03b1-synuclein, the main component of Lewy bodies, could be transmitted from the host brain to a graft of healthy neurons",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20846907",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15541000",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "alpha-Synuclein and ubiquitin are two Lewy body protein components that may play antagonistic roles in the pathogenesis of Lewy bodies",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11085897",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recently, the presynaptic protein alpha-synuclein was shown to be a major component of Lewy bodies and Lewy neurites",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10327208",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Alpha-synuclein (AS) is the main component of Lewy bodies and its aggregation is a key event in the pathogenesis of PD",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21683963",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18991634",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016631",
    "http://www.disease-ontology.org/api/metadata/DOID:12217",
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020961"
  ],
  "exact_answer": "Alpha-synuclein"
}